Slovakia offers a 100% deduction of eligible costs from the income base, providing a net benefit
of 21% on the cost of R&D. There is an additional deduction that can be applied to any incremental
increase between current and previous two years of QE, equating to an additional 21% benefit.
There is a certain lack of clarity regarding how the legislation should be interpreted, but the Finance
Administration has been taking steps to help in this regard.